[{"path":"https://txx4986.github.io/aeplots/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"MIT License","title":"MIT License","text":"Copyright (c) 2023 aeplots authors Permission hereby granted, free charge, person obtaining copy software associated documentation files (“Software”), deal Software without restriction, including without limitation rights use, copy, modify, merge, publish, distribute, sublicense, /sell copies Software, permit persons Software furnished , subject following conditions: copyright notice permission notice shall included copies substantial portions Software. SOFTWARE PROVIDED “”, WITHOUT WARRANTY KIND, EXPRESS IMPLIED, INCLUDING LIMITED WARRANTIES MERCHANTABILITY, FITNESS PARTICULAR PURPOSE NONINFRINGEMENT. EVENT SHALL AUTHORS COPYRIGHT HOLDERS LIABLE CLAIM, DAMAGES LIABILITY, WHETHER ACTION CONTRACT, TORT OTHERWISE, ARISING , CONNECTION SOFTWARE USE DEALINGS SOFTWARE.","code":""},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Adverse Event Data","text":"vignette documents use functions aeplots create tables plots analysing adverse event data clinical trials.","code":"library(aeplots)"},{"path":[]},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"treatment-arms","dir":"Articles","previous_headings":"Input data","what":"2 treatment arms","title":"Adverse Event Data","text":"generate tables plots summarise adverse events clinical trials, R package requires input dataset data frame format. sample dataset two treatment arms shown : Note participant experience adverse events, row included input dataset stating /id, arm, date_rand, last_visit variables included model. adverse_event, body_system_class severity column specified NA. example: need convert body_system_class severity columns factors. Note functions , need specify column names corresponding variable needed unless rename column names dataset default column names specified sample dataset documentation. refer detailed documentation function typing:","code":"data(df2) head(df2, 10) tail(df2 %>%         add_row(id=2110, arm=\"Intervention\", ae_pt=NA, aebodsys=NA, severity=NA, date_rand=ymd(\"2015-05-22\"),                last_visit=ymd(\"2016-04-22\"), variable1=2, variable2=1500), 1) df2$aebodsys <- as.factor(df2$aebodsys) # for severity to be presented in ascending order, we order the levels df2$severity <- ordered(df2$severity, c(\"Mild\", \"Moderate\", \"Severe\")) help(aetable)"},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"more-than-2-treatment-arms","dir":"Articles","previous_headings":"Input data","what":"More than 2 treatment arms","title":"Adverse Event Data","text":"functions aetable, aeseverity, aestacked aebar can take 4 treatment arms. sample dataset 3 treatment arms:","code":"data(df3) head(df3, 10) df3$aebodsys <- as.factor(df3$aebodsys) df3$severity <- ordered(df2$severity, c(\"Mild\", \"Moderate\", \"Severe\"))"},{"path":[]},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"treatment-arms-1","dir":"Articles","previous_headings":"aetable function","what":"2 treatment arms","title":"Adverse Event Data","text":"aetable plots table AE summary body system class arm. contains total number participants risk per arm (\\(N_{1}\\), \\(N_{2}\\)), frequency (N), proportion (%), total number events (n), incidence rate (IR), number adverse events per participant (mean & SD) treatment effect estimate 95% confidence interval (CI). include additional covariates besides arm model, specify vector variable names variables argument.  can specify model used estimate treatment effect 95% CI via model argument. available model options Poisson (rate), Poisson (count), Negative Binomial (rate), Negative Binomial (count), Binomial (logit), Binomial (log) Binomial (identity).  can specify IR per number person via IR_per_person argument. default IR per 100 person.  can specify number decimal places proportions, IR, mean SD columns well number significant figures treatment effect estimate 95% CI.  can choose drop treatment effect estimate 95% CI specifying treatment_effect_estimate=FALSE.  can also choose drop mean column specifying mean=FALSE.","code":"aetable(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention_levels=c(\"Intervention\"),         treatment_effect_estimate=TRUE, variables = c(\"variable1\", \"variable2\")) aetable(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention_levels=c(\"Intervention\"),         treatment_effect_estimate=TRUE, model=\"Binomial (logit)\", variables = c(\"variable1\", \"variable2\")) aetable(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention_levels=c(\"Intervention\"),         IR_per_person=1000) aetable(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention_levels=c(\"Intervention\"),         treatment_effect_estimate=TRUE, variables = c(\"variable1\", \"variable2\"), proportions_dp=2, IR_dp=2,         mean_dp=2, SD_dp=2, estimate_sf=4, CI_sf=4) aetable(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention_levels=c(\"Intervention\"),         treatment_effect_estimate=FALSE) aetable(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention_levels=c(\"Intervention\"),         treatment_effect_estimate=FALSE, mean=FALSE)"},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"more-than-2-treatment-arms-1","dir":"Articles","previous_headings":"aetable function","what":"More than 2 treatment arms","title":"Adverse Event Data","text":"aetable include treatment effect estimates 95% CIs datasets 2 treatment arms. change labels control interventions table, specify label control argument control_name specify intervention labels argument intervention_names. Note intervention_names specified using order interventions specified intervention_levels.","code":"aetable(df3, body_system_class=\"aebodsys\", control=\"Placebo\", control_name=\"No Drug\",         intervention_levels=c(\"Intervention 1\", \"Intervention 2\"), intervention_names=c(\"Drug A\", \"Drug B\"))"},{"path":[]},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"treatment-arms-2","dir":"Articles","previous_headings":"aeseverity function","what":"2 treatment arms","title":"Adverse Event Data","text":"aeseverity plots table frequencies proportions events severity categories. specify number decimal places proportions via argument proportions_dp.  can choose drop number events column specifying n_events=FALSE.","code":"aeseverity(df2, arm_levels=c(\"Intervention\", \"Placebo\"), body_system_class=\"aebodsys\", proportions_dp=2) aeseverity(df2, arm_levels=c(\"Intervention\", \"Placebo\"), body_system_class=\"aebodsys\", n_events=FALSE)"},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"more-than-2-treatment-arms-2","dir":"Articles","previous_headings":"aeseverity function","what":"More than 2 treatment arms","title":"Adverse Event Data","text":"","code":"aeseverity(df3, arm_levels=c(\"Intervention 1\", \"Intervention 2\", \"Placebo\"),             arm_names=c(\"Drug A\", \"Drug B\", \"No Drug\"), body_system_class=\"aebodsys\", n_events=FALSE)"},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"aedot-function","dir":"Articles","previous_headings":"","what":"aedot function","title":"Adverse Event Data","text":"aedot plots dot plot proportions alongside treatment effect estimates accompanying 95% confidence interval visualise AE harm profiles two-arm randomised controlled trials.  Similar aetable, can specify model used estimate treatment effect 95% CI via model argument. available model options unadjusted (RR), unadjusted (RD), Poisson (rate), Poisson (count), Negative Binomial (rate), Negative Binomial (count), Binomial (logit), Binomial (log) Binomial (identity).  can change colours dots percentage participants plot dot_colours argument.","code":"aedot(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention=\"Intervention\") aedot(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention=\"Intervention\", model=\"unadjusted (RD)\") aedot(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention=\"Intervention\",        dot_colours=c(\"#F4B800\", \"#97D800\"))"},{"path":[]},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"treatment-arms-3","dir":"Articles","previous_headings":"aestacked function","what":"2 treatment arms","title":"Adverse Event Data","text":"aestacked plots stacked bar chart proportions body system class arm maximum severity. severity ordered, required specify levels severity ascending order argument severity_levels.  can change colour severity specifying vector colour codes corresponding severity level severity_colours argument.","code":"aestacked(df2, body_system_class=\"aebodsys\", arm_levels=c(\"Intervention\",\"Placebo\"),            severity_levels=c(\"Mild\", \"Moderate\", \"Severe\")) aestacked(df2, body_system_class=\"aebodsys\", arm_levels=c(\"Intervention\",\"Placebo\"),            severity_levels=c(\"Mild\", \"Moderate\", \"Severe\"), severity_colours=c(\"#D0EE11\", \"#48B5C4\", \"#115F9A\"))"},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"more-than-2-treatment-arms-3","dir":"Articles","previous_headings":"aestacked function","what":"More than 2 treatment arms","title":"Adverse Event Data","text":"","code":"aestacked(df3, body_system_class=\"aebodsys\", arm_levels=c(\"Intervention 1\",\"Intervention 2\", \"Placebo\"),           arm_names=c(\"Drug A\",\"Drug B\", \"No Drug\"), severity_levels=c(\"Mild\", \"Moderate\", \"Severe\"))"},{"path":[]},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"treatment-arms-4","dir":"Articles","previous_headings":"aebar function","what":"2 treatment arms","title":"Adverse Event Data","text":"aebar plots bar chart number events reported per participant.  can change colour representing treatment arm specifying vector colour codes arm_colours argument according order arm levels specified arm_levels argument.","code":"aebar(df2, arm_levels=c(\"Intervention\",\"Placebo\"), adverse_event=\"ae_pt\", facets=FALSE) aebar(df2, arm_levels=c(\"Intervention\",\"Placebo\"), adverse_event=\"ae_pt\", arm_colours=c(\"#FFB55A\", \"#B2E061\"), facets=FALSE)"},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"more-than-2-treatment-arms-4","dir":"Articles","previous_headings":"aebar function","what":"More than 2 treatment arms","title":"Adverse Event Data","text":"can plot bar chart treatment arm separate facets specifying facets=TRUE.","code":"aebar(df3, arm_levels=c(\"Intervention 1\",\"Intervention 2\", \"Placebo\"), arm_names=c(\"Drug A\",\"Drug B\", \"No Drug\"),       adverse_event=\"ae_pt\", facets=FALSE) aebar(df3, arm_levels=c(\"Intervention 1\",\"Intervention 2\", \"Placebo\"), arm_names=c(\"Drug A\",\"Drug B\", \"No Drug\"),       adverse_event=\"ae_pt\", facets=TRUE)"},{"path":[]},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"docx","dir":"Articles","previous_headings":"Saving tables and plots","what":"Docx","title":"Adverse Event Data","text":"can save tables docx specifying filepath save_docx_path argument.","code":"aetable(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention_levels=c(\"Intervention\"),         treatment_effect_estimate=TRUE, variables = c(\"variable1\", \"variable2\"), save_docx_path=\"aetable.docx\")"},{"path":"https://txx4986.github.io/aeplots/articles/adverse-event-data.html","id":"image","dir":"Articles","previous_headings":"Saving tables and plots","what":"Image","title":"Adverse Event Data","text":"can save tables plots images specifying filepath save_image_path argument.","code":"aebar(df3, arm_levels=c(\"Intervention 1\",\"Intervention 2\", \"Placebo\"), arm_names=c(\"Drug A\",\"Drug B\", \"No Drug\"),       adverse_event=\"ae_pt\", facets=TRUE, save_image_path=\"aeimage.png\") #> Saving 8 x 6 in image"},{"path":"https://txx4986.github.io/aeplots/articles/laboratory-data.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Laboratory Data","text":"article documents use functions aeplots analyse laboratory data clinical trials.","code":"library(aeplots)"},{"path":[]},{"path":"https://txx4986.github.io/aeplots/articles/laboratory-data.html","id":"treatment-arms","dir":"Articles","previous_headings":"Input data","what":"2 treatment arms","title":"Laboratory Data","text":"generate tables plots summarise laboratory data clinical trials, R package requires input dataset data frame format. sample dataset two treatment arms shown : need convert visit column ordered factor. Note functions , need specify column names corresponding variable needed unless rename column names dataset default column names specified sample dataset documentation. refer detailed documentation function typing:","code":"data(lab2) head(lab2, 10) lab2$visit <- ordered(lab2$visit, c(\"Week 0\", \"Week 4\", \"Week 8\", \"Week 12\", \"Week 16\", \"Week 20\", \"Week 24\")) help(labtable)"},{"path":"https://txx4986.github.io/aeplots/articles/laboratory-data.html","id":"more-than-2-treatment-arms","dir":"Articles","previous_headings":"Input data","what":"More than 2 treatment arms","title":"Laboratory Data","text":"function labtable can take 4 treatment arms. sample dataset 3 treatment arms:","code":"data(lab3) tail(lab3, 10)"},{"path":[]},{"path":"https://txx4986.github.io/aeplots/articles/laboratory-data.html","id":"treatment-arms-1","dir":"Articles","previous_headings":"labtable function","what":"2 treatment arms","title":"Laboratory Data","text":"labtable plots table summarises laboratory values continuous outcomes baseline post-baseline timepoint treatment arms. contains mean & standard deviation (SD), median & interquartile range (IQR), number missing observations treatment effect estimate 95% confidence interval (CI).    Intervention (N₁=66) Placebo (N₂=69) Treatment effect estimate (95% CI) Alanine Aminotransferase (IU/L) Week 0 Mean (SD) 56.6 (32) 61.1 (34.9) NA (NA, NA) Median (IQR) 55 (52.6) 56.2 (58) Number missing n 1 0 Week 4 Mean (SD) 61.6 (35.8) 61.6 (35.1) Median (IQR) 56.6 (69.5) 61.8 (59.1) Number missing n 3 2 Week 8 Mean (SD) 57.6 (32.5) 64.4 (32.3) Median (IQR) 53.3 (50.5) 68.8 (58.1) Number missing n 3 1 Week 12 Mean (SD) 60.8 (31.2) 61.7 (34.3) Median (IQR) 64.9 (47.4) 59.3 (55.2) Number missing n 3 4 Week 16 Mean (SD) NA (NA) 92.5 (NA) Median (IQR) NA (NA) 92.5 (0) Number missing n 66 68 Week 20 Mean (SD) 61.3 (35) 55.4 (30.8) Median (IQR) 68.4 (63.3) 60.6 (50.6) Number missing n 3 4 Week 24 Mean (SD) 60.1 (31.3) 61.2 (32.6) Median (IQR) 60.9 (53.9) 60.1 (52.9) Number missing n 4 5 Lymphocytes (GI/L) Week 0 Mean (SD) 3.6 (1.9) 3.2 (2) Median (IQR) 3.5 (3.3) 3 (3.2) Number missing n 1 2 Week 4 Mean (SD) 3.6 (1.8) 3.8 (2.1) Median (IQR) 3.6 (2.5) 3.7 (3.8) Number missing n 4 4 Week 8 Mean (SD) 3.8 (2.1) 4.2 (1.9) Median (IQR) 3.5 (3.9) 4.4 (3.6) Number missing n 3 2 Week 12 Mean (SD) 3.8 (1.9) 4.1 (1.9) Median (IQR) 4 (2.9) 4.3 (3.1) Number missing n 3 3 Week 16 Mean (SD) 3.9 (2.1) 4.1 (2) Median (IQR) 3.8 (3.9) 4.2 (3.4) Number missing n 2 5 Week 20 Mean (SD) 3.9 (1.8) 4 (2) Median (IQR) 4 (2.5) 4.1 (3.3) Number missing n 4 3 Week 24 Mean (SD) 3.5 (1.9) 3.9 (2.2) Median (IQR) 3.4 (3.4) 3.7 (3.9) Number missing n 4 4 Neutrophils (GI/L) Week 0 Mean (SD) 12.6 (6.5) 12 (7) Median (IQR) 13.8 (11.5) 11.4 (12.5) Number missing n 1 2 Week 4 Mean (SD) 12.9 (6.4) 11.3 (6.8) Median (IQR) 12.9 (11.5) 11 (12.3) Number missing n 4 4 Week 8 Mean (SD) 11.8 (7.1) 11.6 (6.8) Median (IQR) 11.8 (13.2) 10.4 (13) Number missing n 3 2 Week 12 Mean (SD) 12.1 (6.8) 12.2 (6.7) Median (IQR) 11.1 (12.5) 11.1 (12.5) Number missing n 3 3 Week 16 Mean (SD) 12.7 (6.8) 11.5 (7.2) Median (IQR) 13 (11.8) 12.2 (13.1) Number missing n 2 5 Week 20 Mean (SD) 11.2 (6.7) 12.1 (6.7) Median (IQR) 10.3 (11.4) 12.2 (10.3) Number missing n 4 3 Week 24 Mean (SD) 12.4 (6.8) 12.6 (6.2) Median (IQR) 13.1 (12) 13.3 (11.5) Number missing n 4 4 can specify linear mixed model used estimate treatment effect 95% CI via model_formula argument. default model aval ~ arm + (1|id).    Intervention (N₁=66) Placebo (N₂=69) Treatment effect estimate (95% CI) Alanine Aminotransferase (IU/L) Week 0 Mean (SD) 56.6 (32) 61.1 (34.9) NA (NA, NA) Median (IQR) 55 (52.6) 56.2 (58) Number missing n 1 0 Week 4 Mean (SD) 61.6 (35.8) 61.6 (35.1) Median (IQR) 56.6 (69.5) 61.8 (59.1) Number missing n 3 2 Week 8 Mean (SD) 57.6 (32.5) 64.4 (32.3) Median (IQR) 53.3 (50.5) 68.8 (58.1) Number missing n 3 1 Week 12 Mean (SD) 60.8 (31.2) 61.7 (34.3) Median (IQR) 64.9 (47.4) 59.3 (55.2) Number missing n 3 4 Week 16 Mean (SD) NA (NA) 92.5 (NA) Median (IQR) NA (NA) 92.5 (0) Number missing n 66 68 Week 20 Mean (SD) 61.3 (35) 55.4 (30.8) Median (IQR) 68.4 (63.3) 60.6 (50.6) Number missing n 3 4 Week 24 Mean (SD) 60.1 (31.3) 61.2 (32.6) Median (IQR) 60.9 (53.9) 60.1 (52.9) Number missing n 4 5 Lymphocytes (GI/L) Week 0 Mean (SD) 3.6 (1.9) 3.2 (2) Median (IQR) 3.5 (3.3) 3 (3.2) Number missing n 1 2 Week 4 Mean (SD) 3.6 (1.8) 3.8 (2.1) Median (IQR) 3.6 (2.5) 3.7 (3.8) Number missing n 4 4 Week 8 Mean (SD) 3.8 (2.1) 4.2 (1.9) Median (IQR) 3.5 (3.9) 4.4 (3.6) Number missing n 3 2 Week 12 Mean (SD) 3.8 (1.9) 4.1 (1.9) Median (IQR) 4 (2.9) 4.3 (3.1) Number missing n 3 3 Week 16 Mean (SD) 3.9 (2.1) 4.1 (2) Median (IQR) 3.8 (3.9) 4.2 (3.4) Number missing n 2 5 Week 20 Mean (SD) 3.9 (1.8) 4 (2) Median (IQR) 4 (2.5) 4.1 (3.3) Number missing n 4 3 Week 24 Mean (SD) 3.5 (1.9) 3.9 (2.2) Median (IQR) 3.4 (3.4) 3.7 (3.9) Number missing n 4 4 Neutrophils (GI/L) Week 0 Mean (SD) 12.6 (6.5) 12 (7) Median (IQR) 13.8 (11.5) 11.4 (12.5) Number missing n 1 2 Week 4 Mean (SD) 12.9 (6.4) 11.3 (6.8) Median (IQR) 12.9 (11.5) 11 (12.3) Number missing n 4 4 Week 8 Mean (SD) 11.8 (7.1) 11.6 (6.8) Median (IQR) 11.8 (13.2) 10.4 (13) Number missing n 3 2 Week 12 Mean (SD) 12.1 (6.8) 12.2 (6.7) Median (IQR) 11.1 (12.5) 11.1 (12.5) Number missing n 3 3 Week 16 Mean (SD) 12.7 (6.8) 11.5 (7.2) Median (IQR) 13 (11.8) 12.2 (13.1) Number missing n 2 5 Week 20 Mean (SD) 11.2 (6.7) 12.1 (6.7) Median (IQR) 10.3 (11.4) 12.2 (10.3) Number missing n 4 3 Week 24 Mean (SD) 12.4 (6.8) 12.6 (6.2) Median (IQR) 13.1 (12) 13.3 (11.5) Number missing n 4 4 can specify number decimal places mean, SD, median IQR columns well number significant figures treatment effect estimate 95% CI.    Intervention (N₁=66) Placebo (N₂=69) Treatment effect estimate (95% CI) Alanine Aminotransferase (IU/L) Week 0 Mean (SD) 56.63 (31.99) 61.12 (34.88) NA (NA, NA) Median (IQR) 55.01 (52.62) 56.21 (57.96) Number missing n 1 0 Week 4 Mean (SD) 61.61 (35.82) 61.56 (35.12) Median (IQR) 56.59 (69.5) 61.81 (59.1) Number missing n 3 2 Week 8 Mean (SD) 57.63 (32.48) 64.42 (32.27) Median (IQR) 53.29 (50.49) 68.79 (58.1) Number missing n 3 1 Week 12 Mean (SD) 60.8 (31.18) 61.66 (34.32) Median (IQR) 64.91 (47.37) 59.26 (55.23) Number missing n 3 4 Week 16 Mean (SD) NA (NA) 92.48 (NA) Median (IQR) NA (NA) 92.48 (0) Number missing n 66 68 Week 20 Mean (SD) 61.29 (35) 55.42 (30.8) Median (IQR) 68.39 (63.3) 60.58 (50.55) Number missing n 3 4 Week 24 Mean (SD) 60.12 (31.32) 61.23 (32.55) Median (IQR) 60.94 (53.86) 60.08 (52.91) Number missing n 4 5 Lymphocytes (GI/L) Week 0 Mean (SD) 3.64 (1.89) 3.21 (1.96) Median (IQR) 3.54 (3.32) 3.04 (3.19) Number missing n 1 2 Week 4 Mean (SD) 3.59 (1.79) 3.85 (2.14) Median (IQR) 3.6 (2.5) 3.68 (3.82) Number missing n 4 4 Week 8 Mean (SD) 3.83 (2.13) 4.16 (1.93) Median (IQR) 3.48 (3.89) 4.43 (3.58) Number missing n 3 2 Week 12 Mean (SD) 3.82 (1.9) 4.13 (1.93) Median (IQR) 3.98 (2.92) 4.31 (3.13) Number missing n 3 3 Week 16 Mean (SD) 3.88 (2.14) 4.08 (2.01) Median (IQR) 3.8 (3.89) 4.22 (3.39) Number missing n 2 5 Week 20 Mean (SD) 3.92 (1.84) 4 (1.96) Median (IQR) 3.99 (2.54) 4.07 (3.26) Number missing n 4 3 Week 24 Mean (SD) 3.52 (1.9) 3.87 (2.21) Median (IQR) 3.39 (3.4) 3.73 (3.94) Number missing n 4 4 Neutrophils (GI/L) Week 0 Mean (SD) 12.6 (6.54) 12.01 (7.05) Median (IQR) 13.84 (11.5) 11.38 (12.46) Number missing n 1 2 Week 4 Mean (SD) 12.94 (6.45) 11.29 (6.76) Median (IQR) 12.93 (11.47) 11.02 (12.29) Number missing n 4 4 Week 8 Mean (SD) 11.8 (7.08) 11.63 (6.78) Median (IQR) 11.8 (13.15) 10.37 (12.95) Number missing n 3 2 Week 12 Mean (SD) 12.08 (6.85) 12.18 (6.74) Median (IQR) 11.13 (12.5) 11.06 (12.47) Number missing n 3 3 Week 16 Mean (SD) 12.67 (6.84) 11.5 (7.17) Median (IQR) 13.04 (11.75) 12.21 (13.07) Number missing n 2 5 Week 20 Mean (SD) 11.24 (6.73) 12.1 (6.67) Median (IQR) 10.32 (11.38) 12.2 (10.31) Number missing n 4 3 Week 24 Mean (SD) 12.36 (6.76) 12.59 (6.21) Median (IQR) 13.08 (12.03) 13.27 (11.46) Number missing n 4 4 can choose drop either Treatment effect estimate (95% CI), Mean (SD), Median (IQR) Number missing n specifying treatment_effect_estimate=FALSE, mean=FALSE, median=FALSE n_missing=FALSE.    Intervention (N₁=66) Placebo (N₂=69) Alanine Aminotransferase (IU/L) Week 0 Mean (SD) 56.6 (32) 61.1 (34.9) Week 4 Mean (SD) 61.6 (35.8) 61.6 (35.1) Week 8 Mean (SD) 57.6 (32.5) 64.4 (32.3) Week 12 Mean (SD) 60.8 (31.2) 61.7 (34.3) Week 16 Mean (SD) NA (NA) 92.5 (NA) Week 20 Mean (SD) 61.3 (35) 55.4 (30.8) Week 24 Mean (SD) 60.1 (31.3) 61.2 (32.6) Lymphocytes (GI/L) Week 0 Mean (SD) 3.6 (1.9) 3.2 (2) Week 4 Mean (SD) 3.6 (1.8) 3.8 (2.1) Week 8 Mean (SD) 3.8 (2.1) 4.2 (1.9) Week 12 Mean (SD) 3.8 (1.9) 4.1 (1.9) Week 16 Mean (SD) 3.9 (2.1) 4.1 (2) Week 20 Mean (SD) 3.9 (1.8) 4 (2) Week 24 Mean (SD) 3.5 (1.9) 3.9 (2.2) Neutrophils (GI/L) Week 0 Mean (SD) 12.6 (6.5) 12 (7) Week 4 Mean (SD) 12.9 (6.4) 11.3 (6.8) Week 8 Mean (SD) 11.8 (7.1) 11.6 (6.8) Week 12 Mean (SD) 12.1 (6.8) 12.2 (6.7) Week 16 Mean (SD) 12.7 (6.8) 11.5 (7.2) Week 20 Mean (SD) 11.2 (6.7) 12.1 (6.7) Week 24 Mean (SD) 12.4 (6.8) 12.6 (6.2)","code":"labtable(lab2, control=\"Placebo\", intervention_levels=c(\"Intervention\")) labtable(lab2, control=\"Placebo\", intervention_levels=c(\"Intervention\"), model_formula=\"aval ~ arm + base + strat + time + (1|id) + (1|region)\") labtable(lab2, control=\"Placebo\", intervention_levels=c(\"Intervention\"), mean_dp=2, SD_dp=2, median_dp=2, IQR_dp=2,          estimate_sf=4, CI_sf=4) labtable(lab2, control=\"Placebo\", intervention_levels=c(\"Intervention\"), treatment_effect_estimate=FALSE,          median=FALSE, n_missing=FALSE)"},{"path":"https://txx4986.github.io/aeplots/articles/laboratory-data.html","id":"more-than-2-treatment-arms-1","dir":"Articles","previous_headings":"labtable function","what":"More than 2 treatment arms","title":"Laboratory Data","text":"labtable include treatment effect estimates 95% CIs datasets 2 treatment arms. change labels control interventions table, specify label control argument control_name specify intervention labels argument intervention_names. Note intervention_names specified using order interventions specified intervention_levels.    Drug (N₁=65) Drug B (N₂=28) Drug (N₃=42) Alanine Aminotransferase (IU/L) Week 0 Mean (SD) 57.3 (30.1) 62.3 (36.1) 59.4 (37.1) Median (IQR) 55.3 (44) 59 (60.5) 55.3 (74) Number missing n 0 1 0 Week 4 Mean (SD) 57.5 (34.4) 62.3 (36.9) 67.8 (35.7) Median (IQR) 52 (57.9) 68.2 (60.5) 67.4 (66.8) Number missing n 1 1 3 Week 8 Mean (SD) 62.5 (33.2) 64.5 (30.5) 57 (32.8) Median (IQR) 62.5 (59.6) 65.2 (50.4) 53.3 (63.3) Number missing n 1 2 1 Week 12 Mean (SD) 61.7 (31.6) 64.9 (34) 58.1 (33.9) Median (IQR) 63.8 (44.4) 67.6 (55.5) 52.6 (58.2) Number missing n 4 1 2 Week 16 Mean (SD) NA (NA) NA (NA) 92.5 (NA) Median (IQR) NA (NA) NA (NA) 92.5 (0) Number missing n 65 28 41 Week 20 Mean (SD) 57.4 (33.4) 58.3 (32.7) 59.7 (33.1) Median (IQR) 58 (56.5) 66.8 (60.1) 62.2 (53.3) Number missing n 3 2 2 Week 24 Mean (SD) 60.8 (34.1) 71.1 (30) 54 (28.1) Median (IQR) 57 (58.6) 69.8 (42.9) 57.2 (35.6) Number missing n 4 3 2 Lymphocytes (GI/L) Week 0 Mean (SD) 3.5 (2) 3.5 (2) 3.2 (1.9) Median (IQR) 3.3 (3.6) 3.2 (3.5) 3 (3.4) Number missing n 3 0 0 Week 4 Mean (SD) 3.8 (1.8) 4.2 (2.2) 3.3 (2) Median (IQR) 3.8 (2.7) 4.2 (3.6) 3.2 (4) Number missing n 3 2 3 Week 8 Mean (SD) 4.2 (2) 3.4 (2) 4.1 (2) Median (IQR) 4.2 (3.9) 3.1 (3.6) 4.2 (3) Number missing n 2 2 1 Week 12 Mean (SD) 3.8 (1.9) 4.4 (1.5) 3.9 (2.1) Median (IQR) 3.9 (3.1) 4.4 (2.7) 3.7 (3.7) Number missing n 3 1 2 Week 16 Mean (SD) 3.9 (2.1) 4 (2) 4.1 (2.2) Median (IQR) 4.1 (3.7) 3.9 (2.4) 4 (4.3) Number missing n 3 2 2 Week 20 Mean (SD) 3.8 (2) 4.3 (1.7) 4 (1.9) Median (IQR) 3.8 (3.6) 4.3 (2.1) 4.1 (2.8) Number missing n 3 2 2 Week 24 Mean (SD) 4 (2.1) 3.8 (2.1) 3.1 (1.9) Median (IQR) 4.1 (3.4) 3.8 (3.8) 3 (2.8) Number missing n 3 2 3 Neutrophils (GI/L) Week 0 Mean (SD) 11.4 (6.8) 11.7 (6.2) 14.1 (7) Median (IQR) 11.1 (11.3) 10.9 (11.2) 16.5 (11.2) Number missing n 3 0 0 Week 4 Mean (SD) 11.5 (6.7) 10.8 (7) 14 (6) Median (IQR) 11 (11.2) 10.3 (10.9) 15.3 (9.1) Number missing n 3 2 3 Week 8 Mean (SD) 11 (7.2) 12.1 (6.6) 12.5 (6.7) Median (IQR) 9.4 (14.4) 11.1 (12.9) 11.9 (11.7) Number missing n 2 2 1 Week 12 Mean (SD) 11.5 (6.4) 13.6 (7) 12.1 (7.2) Median (IQR) 11.2 (11) 12.6 (13.4) 9.8 (13.5) Number missing n 3 1 2 Week 16 Mean (SD) 12 (7.5) 12.2 (6.9) 12.2 (6.5) Median (IQR) 12.6 (14.1) 13.6 (12.3) 12.3 (11.1) Number missing n 3 2 2 Week 20 Mean (SD) 10.8 (6.6) 13.6 (6) 11.8 (7.1) Median (IQR) 9.4 (10.7) 12.9 (8.6) 12.8 (12.9) Number missing n 3 2 2 Week 24 Mean (SD) 11.3 (6.6) 13 (5.8) 14 (6.5) Median (IQR) 10.6 (10.4) 13.7 (10.8) 14.8 (12.5) Number missing n 3 2 3","code":"labtable(lab3, control=\"Placebo\", control_name=\"No Drug\",           intervention_levels=c(\"Intervention 1\", \"Intervention 2\"), intervention_names=c(\"Drug A\", \"Drug B\"))"},{"path":[]},{"path":"https://txx4986.github.io/aeplots/articles/laboratory-data.html","id":"docx","dir":"Articles","previous_headings":"Saving tables and plots","what":"Docx","title":"Laboratory Data","text":"can save tables docx specifying filepath save_docx_path argument.    Intervention (N₁=66) Placebo (N₂=69) Treatment effect estimate (95% CI) Alanine Aminotransferase (IU/L) Week 0 Mean (SD) 56.6 (32) 61.1 (34.9) NA (NA, NA) Median (IQR) 55 (52.6) 56.2 (58) Number missing n 1 0 Week 4 Mean (SD) 61.6 (35.8) 61.6 (35.1) Median (IQR) 56.6 (69.5) 61.8 (59.1) Number missing n 3 2 Week 8 Mean (SD) 57.6 (32.5) 64.4 (32.3) Median (IQR) 53.3 (50.5) 68.8 (58.1) Number missing n 3 1 Week 12 Mean (SD) 60.8 (31.2) 61.7 (34.3) Median (IQR) 64.9 (47.4) 59.3 (55.2) Number missing n 3 4 Week 16 Mean (SD) NA (NA) 92.5 (NA) Median (IQR) NA (NA) 92.5 (0) Number missing n 66 68 Week 20 Mean (SD) 61.3 (35) 55.4 (30.8) Median (IQR) 68.4 (63.3) 60.6 (50.6) Number missing n 3 4 Week 24 Mean (SD) 60.1 (31.3) 61.2 (32.6) Median (IQR) 60.9 (53.9) 60.1 (52.9) Number missing n 4 5 Lymphocytes (GI/L) Week 0 Mean (SD) 3.6 (1.9) 3.2 (2) Median (IQR) 3.5 (3.3) 3 (3.2) Number missing n 1 2 Week 4 Mean (SD) 3.6 (1.8) 3.8 (2.1) Median (IQR) 3.6 (2.5) 3.7 (3.8) Number missing n 4 4 Week 8 Mean (SD) 3.8 (2.1) 4.2 (1.9) Median (IQR) 3.5 (3.9) 4.4 (3.6) Number missing n 3 2 Week 12 Mean (SD) 3.8 (1.9) 4.1 (1.9) Median (IQR) 4 (2.9) 4.3 (3.1) Number missing n 3 3 Week 16 Mean (SD) 3.9 (2.1) 4.1 (2) Median (IQR) 3.8 (3.9) 4.2 (3.4) Number missing n 2 5 Week 20 Mean (SD) 3.9 (1.8) 4 (2) Median (IQR) 4 (2.5) 4.1 (3.3) Number missing n 4 3 Week 24 Mean (SD) 3.5 (1.9) 3.9 (2.2) Median (IQR) 3.4 (3.4) 3.7 (3.9) Number missing n 4 4 Neutrophils (GI/L) Week 0 Mean (SD) 12.6 (6.5) 12 (7) Median (IQR) 13.8 (11.5) 11.4 (12.5) Number missing n 1 2 Week 4 Mean (SD) 12.9 (6.4) 11.3 (6.8) Median (IQR) 12.9 (11.5) 11 (12.3) Number missing n 4 4 Week 8 Mean (SD) 11.8 (7.1) 11.6 (6.8) Median (IQR) 11.8 (13.2) 10.4 (13) Number missing n 3 2 Week 12 Mean (SD) 12.1 (6.8) 12.2 (6.7) Median (IQR) 11.1 (12.5) 11.1 (12.5) Number missing n 3 3 Week 16 Mean (SD) 12.7 (6.8) 11.5 (7.2) Median (IQR) 13 (11.8) 12.2 (13.1) Number missing n 2 5 Week 20 Mean (SD) 11.2 (6.7) 12.1 (6.7) Median (IQR) 10.3 (11.4) 12.2 (10.3) Number missing n 4 3 Week 24 Mean (SD) 12.4 (6.8) 12.6 (6.2) Median (IQR) 13.1 (12) 13.3 (11.5) Number missing n 4 4","code":"labtable(lab2, control=\"Placebo\", intervention_levels=c(\"Intervention\"), save_docx_path=\"labtable.docx\")"},{"path":"https://txx4986.github.io/aeplots/articles/laboratory-data.html","id":"image","dir":"Articles","previous_headings":"Saving tables and plots","what":"Image","title":"Laboratory Data","text":"can save tables plots images specifying filepath save_image_path argument.    Intervention (N₁=66) Placebo (N₂=69) Treatment effect estimate (95% CI) Alanine Aminotransferase (IU/L) Week 0 Mean (SD) 56.6 (32) 61.1 (34.9) NA (NA, NA) Median (IQR) 55 (52.6) 56.2 (58) Number missing n 1 0 Week 4 Mean (SD) 61.6 (35.8) 61.6 (35.1) Median (IQR) 56.6 (69.5) 61.8 (59.1) Number missing n 3 2 Week 8 Mean (SD) 57.6 (32.5) 64.4 (32.3) Median (IQR) 53.3 (50.5) 68.8 (58.1) Number missing n 3 1 Week 12 Mean (SD) 60.8 (31.2) 61.7 (34.3) Median (IQR) 64.9 (47.4) 59.3 (55.2) Number missing n 3 4 Week 16 Mean (SD) NA (NA) 92.5 (NA) Median (IQR) NA (NA) 92.5 (0) Number missing n 66 68 Week 20 Mean (SD) 61.3 (35) 55.4 (30.8) Median (IQR) 68.4 (63.3) 60.6 (50.6) Number missing n 3 4 Week 24 Mean (SD) 60.1 (31.3) 61.2 (32.6) Median (IQR) 60.9 (53.9) 60.1 (52.9) Number missing n 4 5 Lymphocytes (GI/L) Week 0 Mean (SD) 3.6 (1.9) 3.2 (2) Median (IQR) 3.5 (3.3) 3 (3.2) Number missing n 1 2 Week 4 Mean (SD) 3.6 (1.8) 3.8 (2.1) Median (IQR) 3.6 (2.5) 3.7 (3.8) Number missing n 4 4 Week 8 Mean (SD) 3.8 (2.1) 4.2 (1.9) Median (IQR) 3.5 (3.9) 4.4 (3.6) Number missing n 3 2 Week 12 Mean (SD) 3.8 (1.9) 4.1 (1.9) Median (IQR) 4 (2.9) 4.3 (3.1) Number missing n 3 3 Week 16 Mean (SD) 3.9 (2.1) 4.1 (2) Median (IQR) 3.8 (3.9) 4.2 (3.4) Number missing n 2 5 Week 20 Mean (SD) 3.9 (1.8) 4 (2) Median (IQR) 4 (2.5) 4.1 (3.3) Number missing n 4 3 Week 24 Mean (SD) 3.5 (1.9) 3.9 (2.2) Median (IQR) 3.4 (3.4) 3.7 (3.9) Number missing n 4 4 Neutrophils (GI/L) Week 0 Mean (SD) 12.6 (6.5) 12 (7) Median (IQR) 13.8 (11.5) 11.4 (12.5) Number missing n 1 2 Week 4 Mean (SD) 12.9 (6.4) 11.3 (6.8) Median (IQR) 12.9 (11.5) 11 (12.3) Number missing n 4 4 Week 8 Mean (SD) 11.8 (7.1) 11.6 (6.8) Median (IQR) 11.8 (13.2) 10.4 (13) Number missing n 3 2 Week 12 Mean (SD) 12.1 (6.8) 12.2 (6.7) Median (IQR) 11.1 (12.5) 11.1 (12.5) Number missing n 3 3 Week 16 Mean (SD) 12.7 (6.8) 11.5 (7.2) Median (IQR) 13 (11.8) 12.2 (13.1) Number missing n 2 5 Week 20 Mean (SD) 11.2 (6.7) 12.1 (6.7) Median (IQR) 10.3 (11.4) 12.2 (10.3) Number missing n 4 3 Week 24 Mean (SD) 12.4 (6.8) 12.6 (6.2) Median (IQR) 13.1 (12) 13.3 (11.5) Number missing n 4 4","code":"labtable(lab2, control=\"Placebo\", intervention_levels=c(\"Intervention\"), save_image_path=\"labimage.png\")"},{"path":"https://txx4986.github.io/aeplots/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Xiao Xuan Tan. Author, maintainer.","code":""},{"path":"https://txx4986.github.io/aeplots/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Tan X (2023). aeplots: Create Tables Plots Analysing Adverse Event Data Clinical Trials. R package version 0.1.0, https://txx4986.github.io/aeplots/.","code":"@Manual{,   title = {aeplots: Create Tables and Plots for Analysing Adverse Event Data in Clinical Trials},   author = {Xiao Xuan Tan},   year = {2023},   note = {R package version 0.1.0},   url = {https://txx4986.github.io/aeplots/}, }"},{"path":"https://txx4986.github.io/aeplots/index.html","id":"aeplots","dir":"","previous_headings":"","what":"Create Tables and Plots for Analysing Adverse Event Data in Clinical Trials","title":"Create Tables and Plots for Analysing Adverse Event Data in Clinical Trials","text":"R package create tables plots analysing adverse event data clinical trials","code":""},{"path":"https://txx4986.github.io/aeplots/index.html","id":"how-to-install","dir":"","previous_headings":"","what":"How to install","title":"Create Tables and Plots for Analysing Adverse Event Data in Clinical Trials","text":"can install aeplots : Please refer devtools documentation instructions set working development environment install devtools depending platform.","code":"# install.packages(\"devtools\") devtools::install_github(\"https://github.com/txx4986/aeplots.git\")"},{"path":"https://txx4986.github.io/aeplots/index.html","id":"adverse-event-data","dir":"","previous_headings":"","what":"Adverse Event Data","title":"Create Tables and Plots for Analysing Adverse Event Data in Clinical Trials","text":"Functions available package: aetable: Plots table AE summary body system class aeseverity: Plots table AE summary severity body system class aedot: Plots dot plot proportions alongside treatment effect estimates accompanying 95% confidence interval give overview harm profile aestacked: Plots stacked bar chart present proportions participants event arm maximum severity aebar: Plots bar chart present number events reported per participant see detailed documentation function: ","code":"help(aetable) ?aetable"},{"path":"https://txx4986.github.io/aeplots/index.html","id":"sample-dataset","dir":"","previous_headings":"Adverse Event Data","what":"Sample dataset","title":"Create Tables and Plots for Analysing Adverse Event Data in Clinical Trials","text":"Note participant experience adverse events, row included input dataset stating /id, arm, date_rand, last_visit variables included model. adverse_event, body_system_class severity column specified NA. example:","code":""},{"path":[]},{"path":"https://txx4986.github.io/aeplots/index.html","id":"laboratory-data","dir":"","previous_headings":"","what":"Laboratory Data","title":"Create Tables and Plots for Analysing Adverse Event Data in Clinical Trials","text":"Functions available package: labtable: Plots table summarises laboratory values continuous outcomes baseline post-baseline timepoint treatment arm see detailed documentation function: ","code":"help(labtable) ?labtable"},{"path":[]},{"path":[]},{"path":"https://txx4986.github.io/aeplots/reference/aebar.html","id":null,"dir":"Reference","previous_headings":"","what":"Bar chart for number of events reported per participant — aebar","title":"Bar chart for number of events reported per participant — aebar","text":"Bar chart number events reported per participant","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aebar.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Bar chart for number of events reported per participant — aebar","text":"","code":"aebar(   data,   arm_levels,   id = \"id\",   arm = \"arm\",   adverse_event = \"adverse_event\",   arm_names = NULL,   arm_colours = NULL,   facets = TRUE,   save_image_path = NULL )"},{"path":"https://txx4986.github.io/aeplots/reference/aebar.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Bar chart for number of events reported per participant — aebar","text":"data data frame adverse_event, id arm columns arm_levels vector factor levels arm variable id name id column arm name arm column adverse_event name adverse_event column arm_names vector names arm arm variable arm_colours vector colours arm facets logical value whether plot bar chart facets save_image_path file path save bar chart image","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aebar.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Bar chart for number of events reported per participant — aebar","text":"Bar chart presenting number events reported per participant","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aebar.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Bar chart for number of events reported per participant — aebar","text":"","code":"aebar(df2, arm_levels=c(\"Intervention\",\"Placebo\"), adverse_event=\"ae_pt\", facets=FALSE)"},{"path":"https://txx4986.github.io/aeplots/reference/aedot.html","id":null,"dir":"Reference","previous_headings":"","what":"Dot plot to visualise AE and harm profiles in two-arm randomised controlled trials — aedot","title":"Dot plot to visualise AE and harm profiles in two-arm randomised controlled trials — aedot","text":"aedot creates plot summarises AE harm profiles via following visualisations: left panel: percentage participants event treatment group central panel: relative risk/ risk difference/ incidence rate ratio/ odds ratio observing event treatment group compared control group, along 95% confidence interval right panel: data table containing number participants least one event number events treatment group","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aedot.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Dot plot to visualise AE and harm profiles in two-arm randomised controlled trials — aedot","text":"","code":"aedot(   data,   control,   intervention,   body_system_class = \"body_system_class\",   id = \"id\",   arm = \"arm\",   date_rand = \"date_rand\",   last_visit = \"last_visit\",   model = \"unadjusted (RR)\",   variables = c(),   dot_colours = c(\"red\", \"blue\"),   save_image_path = NULL )"},{"path":"https://txx4986.github.io/aeplots/reference/aedot.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Dot plot to visualise AE and harm profiles in two-arm randomised controlled trials — aedot","text":"data data frame adverse_event, body_system_class, id arm columns (optional: date_rand, last_visit variables included model) control factor level control arm intervention factor level intervention arm body_system_class name body_system_class column id name id column arm name arm column date_rand name date_rand column last_visit name last_visit column model unadjusted relative risk/risk difference model used computation treatment effect estimate 95% CI variables vector variable names included model computation treatment effect estimate (excluding arm) dot_colours vector colours dots percentage participants plot (left plot) save_image_path file path save dot plot image","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aedot.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Dot plot to visualise AE and harm profiles in two-arm randomised controlled trials — aedot","text":"dot plot proportions alongside treatment effect estimates accompanying 95% confidence interval","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aedot.html","id":"treatment-effect-estimate","dir":"Reference","previous_headings":"","what":"Treatment Effect Estimate","title":"Dot plot to visualise AE and harm profiles in two-arm randomised controlled trials — aedot","text":"treatment effect 95% confidence interval estimated via following models : unadjusted (RR): unadjusted relative risk unadjusted (RD): unadjusted risk difference Poisson (rate): fitting generalised linear model Poisson family log link length follow time offset Poisson (count): fitting generalised linear model Poisson family log link count response Negative Binomial (rate): fitting Negative Binomial model length follow time offset Negative Binomial (count): fitting Negative Binomial model count response Binomial (logit): fitting generalised linear model Binomial family logit link Binomial (log): fitting generalised linear model Binomial family log link Binomial (identity): fitting generalised linear model Binomial family identity link default model unadjusted (RR) model. Poisson Negative Binomial models, treatment effect estimate Incidence Rate Ratio (IRR). Binomial (logit) model, treatment effect estimate Odds Ratio (). Binomial (log) model, treatment effect estimate Relative Risk (RR). Binomial (identity) model, treatment effect estimate Risk Difference (RD). reference group treatment arm regression model control arm. Additional covariates besides arm can added model via argument variables. Note interaction terms added model.","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aedot.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Dot plot to visualise AE and harm profiles in two-arm randomised controlled trials — aedot","text":"","code":"df2$aebodsys <- as.factor(df2$aebodsys) aedot(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention=\"Intervention\") #> Bin width defaults to 1/30 of the range of the data. Pick better value with #> `binwidth`."},{"path":"https://txx4986.github.io/aeplots/reference/aeseverity.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of frequencies and proportions of events by severity categories — aeseverity","title":"Table of frequencies and proportions of events by severity categories — aeseverity","text":"aeseverity used plot table AE summary severity level body system class arm using following summary statistics: N: Frequency (number participants least one event severity level body system class) %: Proportions (number participants least one event severity level body system class relative number participants risk) n: Number adverse events severity level body system class Note aeseverity can take 5 severity levels severity variable.","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aeseverity.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of frequencies and proportions of events by severity categories — aeseverity","text":"","code":"aeseverity(   data,   arm_levels,   severity_levels = NULL,   body_system_class = \"body_system_class\",   severity = \"severity\",   id = \"id\",   arm = \"arm\",   n_events = TRUE,   arm_names = NULL,   severity_names = NULL,   proportions_dp = 1,   save_image_path = NULL,   save_docx_path = NULL )"},{"path":"https://txx4986.github.io/aeplots/reference/aeseverity.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of frequencies and proportions of events by severity categories — aeseverity","text":"data data frame adverse_event, body_system_class, severity, id arm columns arm_levels vector factor levels arm variable severity_levels vector severity levels ascending order severity ordered factor body_system_class name body_system_class column severity name severity column id name id column arm name arm column n_events logical value whether include number events body system class severity arm_names vector names arm arm variable severity_names vector names severity severity variable proportions_dp number decimal places proportions save_image_path file path save table image save_docx_path file path save table docx","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aeseverity.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of frequencies and proportions of events by severity categories — aeseverity","text":"flextable frequencies proportions events severity categories","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aeseverity.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of frequencies and proportions of events by severity categories — aeseverity","text":"","code":"df2$aebodsys <- as.factor(df2$aebodsys) df2$severity <- ordered(df2$severity, c(\"Mild\", \"Moderate\", \"Severe\")) aeseverity(df2, arm_levels=c(\"Intervention\",\"Placebo\"), body_system_class=\"aebodsys\", proportions_dp=2)"},{"path":"https://txx4986.github.io/aeplots/reference/aestacked.html","id":null,"dir":"Reference","previous_headings":"","what":"Stacked bar chart of proportions for each body system class by arm and maximum severity — aestacked","title":"Stacked bar chart of proportions for each body system class by arm and maximum severity — aestacked","text":"Stacked bar chart proportions body system class arm maximum severity","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aestacked.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Stacked bar chart of proportions for each body system class by arm and maximum severity — aestacked","text":"","code":"aestacked(   data,   arm_levels,   body_system_class = \"body_system_class\",   severity = \"severity\",   id = \"id\",   arm = \"arm\",   arm_names = NULL,   severity_levels = NULL,   severity_colours = NULL,   save_image_path = NULL )"},{"path":"https://txx4986.github.io/aeplots/reference/aestacked.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Stacked bar chart of proportions for each body system class by arm and maximum severity — aestacked","text":"data data frame adverse_event, body_system_class, severity, id arm columns arm_levels vector factor levels arm variable body_system_class name body_system_class column severity name severity column id name id column arm name arm column arm_names vector names arm arm variable severity_levels vector level severity ascending order severity ordered factor severity_colours vector colours level severity ascending order save_image_path file path save stacked bar chart plot image","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aestacked.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Stacked bar chart of proportions for each body system class by arm and maximum severity — aestacked","text":"stacked bar chart presenting proportions participants event arm maximum severity","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aestacked.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Stacked bar chart of proportions for each body system class by arm and maximum severity — aestacked","text":"","code":"df2$aebodsys <- as.factor(df2$aebodsys) df2$severity <- ordered(df2$severity, c(\"Mild\", \"Moderate\", \"Severe\")) aestacked(df2, body_system_class=\"aebodsys\", arm_levels=c(\"Intervention\",\"Placebo\"), severity_levels=c(\"Mild\", \"Moderate\", \"Severe\"))"},{"path":"https://txx4986.github.io/aeplots/reference/aetable.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of AE summary by body system class — aetable","title":"Table of AE summary by body system class — aetable","text":"aetable used plot table AE summary body system class arm using following summary statistics: Total number participants risk per arm Frequency (number participants least one event body system class) Proportions (number participants least one event body system class relative number participants risk) Number adverse events per participant: presented counts, mean (SD) Total number events incidence rates (number events relative total time follow-) Treatment effect estimate 95% confidence intervals","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aetable.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of AE summary by body system class — aetable","text":"","code":"aetable(   data,   control,   intervention_levels,   body_system_class = \"body_system_class\",   id = \"id\",   arm = \"arm\",   date_rand = \"date_rand\",   last_visit = \"last_visit\",   control_name = NULL,   intervention_names = NULL,   treatment_effect_estimate = TRUE,   model = \"Poisson (rate)\",   variables = c(),   mean = TRUE,   drop_bodsys = TRUE,   IR_per_person = 100,   proportions_dp = 1,   IR_dp = 1,   mean_dp = 1,   SD_dp = 1,   estimate_sf = 3,   CI_sf = 3,   save_image_path = NULL,   save_docx_path = NULL )"},{"path":"https://txx4986.github.io/aeplots/reference/aetable.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of AE summary by body system class — aetable","text":"data data frame adverse_event, body_system_class, id, arm, date_rand last_visit columns (optional: variables included model) control factor level control arm intervention_levels vector factor levels interventions body_system_class name body_system_class column id name id column arm name arm column date_rand name date_rand column last_visit name last_visit column control_name name control arm intervention_names vector names interventions treatment_effect_estimate logical value whether include treatment effect estimate 95% CI column summary table (2 arms) model model used computation treatment effect estimate 95% CI variables vector variable names included model computation treatment effect estimate (excluding arm) mean logical value whether include mean SD column summary table drop_bodsys logical value whether drop body system class observations summary table IR_per_person incidence rate per number person proportions_dp number decimal places proportions IR_dp number decimal places incidence rate mean_dp number decimal places mean number AEs per participant SD_dp number decimal places standard deviation number AEs per participant estimate_sf number significant figures treatment effect estimate CI_sf number significant figures 95% CI save_image_path file path save table image save_docx_path file path save table docx","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aetable.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of AE summary by body system class — aetable","text":"flextable AE summary body system class arm","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aetable.html","id":"treatment-effect-estimate","dir":"Reference","previous_headings":"","what":"Treatment Effect Estimate","title":"Table of AE summary by body system class — aetable","text":"treatment effect 95% confidence interval estimated via following models : Poisson (rate): fitting generalised linear model Poisson family log link length follow time offset Poisson (count): fitting generalised linear model Poisson family log link count response Negative Binomial (rate): fitting Negative Binomial model length follow time offset Negative Binomial (count): fitting Negative Binomial model count response Binomial (logit): fitting generalised linear model Binomial family logit link Binomial (log): fitting generalised linear model Binomial family log link Binomial (identity): fitting generalised linear model Binomial family identity link default model Poisson (rate) model. Poisson Negative Binomial models, treatment effect estimate Incidence Rate Ratio (IRR). Binomial (logit) model, treatment effect estimate Odds Ratio (). Binomial (log) model, treatment effect estimate Risk Ratio (RR). Binomial (identity) model, treatment effect estimate Risk Difference (RD). reference group treatment arm regression model control arm. Additional covariates besides arm can added model via argument variables. Note interaction terms added model.","code":""},{"path":"https://txx4986.github.io/aeplots/reference/aetable.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of AE summary by body system class — aetable","text":"","code":"df2$aebodsys <- as.factor(df2$aebodsys) aetable(df2, body_system_class=\"aebodsys\", control=\"Placebo\", intervention_levels=c(\"Intervention\"), treatment_effect_estimate=TRUE, variables = c(\"variable1\", \"variable2\"))"},{"path":"https://txx4986.github.io/aeplots/reference/df2.html","id":null,"dir":"Reference","previous_headings":"","what":"Sample adverse event dataset with 2 treatment arms — df2","title":"Sample adverse event dataset with 2 treatment arms — df2","text":"Sample adverse event dataset 2 treatment arms","code":""},{"path":"https://txx4986.github.io/aeplots/reference/df2.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Sample adverse event dataset with 2 treatment arms — df2","text":"","code":"df2"},{"path":"https://txx4986.github.io/aeplots/reference/df2.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Sample adverse event dataset with 2 treatment arms — df2","text":"data frame 370 rows 9 variables: id Participant's id arm Treatment arm: Placebo & Intervention ae_pt Adverse event preferred term aebodsys Body system class severity Severity date_rand Date randomisation last_visit Date last visit variable1 Variable 1 included Poisson regression variable2 Variable 2 included Poisson regression","code":""},{"path":"https://txx4986.github.io/aeplots/reference/df3.html","id":null,"dir":"Reference","previous_headings":"","what":"Sample adverse event dataset with 3 treatment arms — df3","title":"Sample adverse event dataset with 3 treatment arms — df3","text":"Sample adverse event dataset 3 treatment arms","code":""},{"path":"https://txx4986.github.io/aeplots/reference/df3.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Sample adverse event dataset with 3 treatment arms — df3","text":"","code":"df3"},{"path":"https://txx4986.github.io/aeplots/reference/df3.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Sample adverse event dataset with 3 treatment arms — df3","text":"data frame 370 rows 7 variables: id Participant's id arm Treatment arm: Placebo, Intervention 1, Intervention 2 ae_pt Adverse event preferred term aebodsys Body system class severity Severity date_rand Date randomisation last_visit Date last visit","code":""},{"path":"https://txx4986.github.io/aeplots/reference/df4.html","id":null,"dir":"Reference","previous_headings":"","what":"Sample adverse event dataset with 4 treatment arms — df4","title":"Sample adverse event dataset with 4 treatment arms — df4","text":"Sample adverse event dataset 4 treatment arms","code":""},{"path":"https://txx4986.github.io/aeplots/reference/df4.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Sample adverse event dataset with 4 treatment arms — df4","text":"","code":"df4"},{"path":"https://txx4986.github.io/aeplots/reference/df4.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Sample adverse event dataset with 4 treatment arms — df4","text":"data frame 370 rows 7 variables: id Participant's id arm Treatment arm: Placebo, Intervention 1, Intervention 2, Intervention 3 ae_pt Adverse event preferred term aebodsys Body system class severity Severity date_rand Date randomisation last_visit Date last visit","code":""},{"path":"https://txx4986.github.io/aeplots/reference/lab2.html","id":null,"dir":"Reference","previous_headings":"","what":"Sample laboratory values with continuous outcomes dataset with 2 treatment arms — lab2","title":"Sample laboratory values with continuous outcomes dataset with 2 treatment arms — lab2","text":"Sample laboratory values continuous outcomes dataset 2 treatment arms","code":""},{"path":"https://txx4986.github.io/aeplots/reference/lab2.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Sample laboratory values with continuous outcomes dataset with 2 treatment arms — lab2","text":"","code":"lab2"},{"path":"https://txx4986.github.io/aeplots/reference/lab2.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Sample laboratory values with continuous outcomes dataset with 2 treatment arms — lab2","text":"data frame 2580 rows 9 variables: id Participant's id arm Treatment arm: Placebo & Intervention visit Timepoint measurement lab_test Laboratory test base Baseline value measurement aval Measurement value region Participant's region strat Stratification variable Time Time measurement","code":""},{"path":"https://txx4986.github.io/aeplots/reference/lab3.html","id":null,"dir":"Reference","previous_headings":"","what":"Sample laboratory values with continuous outcomes dataset with 3 treatment arms — lab3","title":"Sample laboratory values with continuous outcomes dataset with 3 treatment arms — lab3","text":"Sample laboratory values continuous outcomes dataset 3 treatment arms","code":""},{"path":"https://txx4986.github.io/aeplots/reference/lab3.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Sample laboratory values with continuous outcomes dataset with 3 treatment arms — lab3","text":"","code":"lab3"},{"path":"https://txx4986.github.io/aeplots/reference/lab3.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Sample laboratory values with continuous outcomes dataset with 3 treatment arms — lab3","text":"data frame 2580 rows 9 variables: id Participant's id arm Treatment arm: Placebo, Intervention 1, Intervention 2 visit Timepoint measurement lab_test Laboratory test base Baseline value measurement aval Measurement value region Participant's region strat Stratification variable Time Time measurement","code":""},{"path":"https://txx4986.github.io/aeplots/reference/lab4.html","id":null,"dir":"Reference","previous_headings":"","what":"Sample laboratory values with continuous outcomes dataset with 3 treatment arms — lab4","title":"Sample laboratory values with continuous outcomes dataset with 3 treatment arms — lab4","text":"Sample laboratory values continuous outcomes dataset 3 treatment arms","code":""},{"path":"https://txx4986.github.io/aeplots/reference/lab4.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Sample laboratory values with continuous outcomes dataset with 3 treatment arms — lab4","text":"","code":"lab4"},{"path":"https://txx4986.github.io/aeplots/reference/lab4.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Sample laboratory values with continuous outcomes dataset with 3 treatment arms — lab4","text":"data frame 2580 rows 9 variables: id Participant's id arm Treatment arm: Placebo, Intervention 1, Intervention 2, Intervention 3 visit Timepoint measurement lab_test Laboratory test base Baseline value measurement aval Measurement value region Participant's region strat Stratification variable Time Time measurement","code":""},{"path":"https://txx4986.github.io/aeplots/reference/labtable.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of summary statistics and model estimates for laboratory values with continuous outcomes — labtable","title":"Table of summary statistics and model estimates for laboratory values with continuous outcomes — labtable","text":"labtable used plot table summarises laboratory values continuous outcomes baseline post-baseline timepoint treatment arms using following summary statistics: Mean (SD) Median (IQR) Number missing n Treatment effect estimate (95% CI)","code":""},{"path":"https://txx4986.github.io/aeplots/reference/labtable.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of summary statistics and model estimates for laboratory values with continuous outcomes — labtable","text":"","code":"labtable(   data,   control,   intervention_levels,   lab_test = \"lab_test\",   visit = \"visit\",   id = \"id\",   arm = \"arm\",   aval = \"aval\",   treatment_effect_estimate = TRUE,   model_formula = \"aval ~ arm + (1|id)\",   mean = TRUE,   median = TRUE,   n_missing = TRUE,   control_name = NULL,   intervention_names = NULL,   mean_dp = 1,   SD_dp = 1,   median_dp = 1,   IQR_dp = 1,   estimate_sf = 3,   CI_sf = 3,   save_image_path = NULL,   save_docx_path = NULL )"},{"path":"https://txx4986.github.io/aeplots/reference/labtable.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of summary statistics and model estimates for laboratory values with continuous outcomes — labtable","text":"data dataframe lab_test, visit, id, arm aval columns (optional: variables included model) control factor level control arm intervention_levels vector factor levels interventions lab_test name lab_test column visit name visit column id name id column arm name arm column aval name aval column treatment_effect_estimate logical value whether include treatment effect estimate 95% CI column model_formula formula linear mixed model estimate treatment effect 95% CI mean logical value whether include mean SD row summary table median logical value whether include median IQR row summary table n_missing logical value whether include number missing n row summary table control_name name control arm intervention_names vector names interventions mean_dp number decimal places mean SD_dp number decimal places standard deviation median_dp number decimal places median IQR_dp number decimal places IQR estimate_sf number significant figures treatment effect estimate CI_sf number significant figures 95% CI save_image_path file path save table image save_docx_path file path save table docx","code":""},{"path":"https://txx4986.github.io/aeplots/reference/labtable.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of summary statistics and model estimates for laboratory values with continuous outcomes — labtable","text":"flextable laboratory values summary baseline post-baseline timepoint treatment arms","code":""},{"path":"https://txx4986.github.io/aeplots/reference/labtable.html","id":"treatment-effect-estimate","dir":"Reference","previous_headings":"","what":"Treatment Effect Estimate","title":"Table of summary statistics and model estimates for laboratory values with continuous outcomes — labtable","text":"treatment effect 95% confidence interval estimated via linear mixed model laboratory measurement response. formula model can specified model_formula argument. default model aval ~ arm + (1|id).","code":""},{"path":"https://txx4986.github.io/aeplots/reference/labtable.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of summary statistics and model estimates for laboratory values with continuous outcomes — labtable","text":"Intervention (N₁=66) Placebo (N₂=69) Treatment effect estimate (95% CI) Alanine Aminotransferase (IU/L) Week 0 Mean (SD) 56.6 (32) 61.1 (34.9) NA (NA, NA) Median (IQR) 55 (52.6) 56.2 (58) Number missing n 1 0 Week 4 Mean (SD) 61.6 (35.8) 61.6 (35.1) Median (IQR) 56.6 (69.5) 61.8 (59.1) Number missing n 3 2 Week 8 Mean (SD) 57.6 (32.5) 64.4 (32.3) Median (IQR) 53.3 (50.5) 68.8 (58.1) Number missing n 3 1 Week 12 Mean (SD) 60.8 (31.2) 61.7 (34.3) Median (IQR) 64.9 (47.4) 59.3 (55.2) Number missing n 3 4 Week 16 Mean (SD) NA (NA) 92.5 (NA) Median (IQR) NA (NA) 92.5 (0) Number missing n 66 68 Week 20 Mean (SD) 61.3 (35) 55.4 (30.8) Median (IQR) 68.4 (63.3) 60.6 (50.6) Number missing n 3 4 Week 24 Mean (SD) 60.1 (31.3) 61.2 (32.6) Median (IQR) 60.9 (53.9) 60.1 (52.9) Number missing n 4 5 Lymphocytes (GI/L) Week 0 Mean (SD) 3.6 (1.9) 3.2 (2) Median (IQR) 3.5 (3.3) 3 (3.2) Number missing n 1 2 Week 4 Mean (SD) 3.6 (1.8) 3.8 (2.1) Median (IQR) 3.6 (2.5) 3.7 (3.8) Number missing n 4 4 Week 8 Mean (SD) 3.8 (2.1) 4.2 (1.9) Median (IQR) 3.5 (3.9) 4.4 (3.6) Number missing n 3 2 Week 12 Mean (SD) 3.8 (1.9) 4.1 (1.9) Median (IQR) 4 (2.9) 4.3 (3.1) Number missing n 3 3 Week 16 Mean (SD) 3.9 (2.1) 4.1 (2) Median (IQR) 3.8 (3.9) 4.2 (3.4) Number missing n 2 5 Week 20 Mean (SD) 3.9 (1.8) 4 (2) Median (IQR) 4 (2.5) 4.1 (3.3) Number missing n 4 3 Week 24 Mean (SD) 3.5 (1.9) 3.9 (2.2) Median (IQR) 3.4 (3.4) 3.7 (3.9) Number missing n 4 4 Neutrophils (GI/L) Week 0 Mean (SD) 12.6 (6.5) 12 (7) Median (IQR) 13.8 (11.5) 11.4 (12.5) Number missing n 1 2 Week 4 Mean (SD) 12.9 (6.4) 11.3 (6.8) Median (IQR) 12.9 (11.5) 11 (12.3) Number missing n 4 4 Week 8 Mean (SD) 11.8 (7.1) 11.6 (6.8) Median (IQR) 11.8 (13.2) 10.4 (13) Number missing n 3 2 Week 12 Mean (SD) 12.1 (6.8) 12.2 (6.7) Median (IQR) 11.1 (12.5) 11.1 (12.5) Number missing n 3 3 Week 16 Mean (SD) 12.7 (6.8) 11.5 (7.2) Median (IQR) 13 (11.8) 12.2 (13.1) Number missing n 2 5 Week 20 Mean (SD) 11.2 (6.7) 12.1 (6.7) Median (IQR) 10.3 (11.4) 12.2 (10.3) Number missing n 4 3 Week 24 Mean (SD) 12.4 (6.8) 12.6 (6.2) Median (IQR) 13.1 (12) 13.3 (11.5) Number missing n 4 4","code":"labtable(lab2, control=\"Placebo\", intervention_levels=c(\"Intervention\")) .cl-22b9a81e{}.cl-22b0dc98{font-family:'DejaVu Sans';font-size:11pt;font-weight:bold;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-22b0dcac{font-family:'DejaVu Sans';font-size:11pt;font-weight:normal;font-style:normal;text-decoration:none;color:rgba(0, 0, 0, 1.00);background-color:transparent;}.cl-22b437da{margin:0;text-align:left;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-22b437e4{margin:0;text-align:center;border-bottom: 0 solid rgba(0, 0, 0, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);padding-bottom:5pt;padding-top:5pt;padding-left:5pt;padding-right:5pt;line-height: 1;background-color:transparent;}.cl-22b4560c{width:2.722in;background-color:rgba(204, 204, 204, 1.00);vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45616{width:0.956in;background-color:rgba(204, 204, 204, 1.00);vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45620{width:1.875in;background-color:rgba(204, 204, 204, 1.00);vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45621{width:1.883in;background-color:rgba(204, 204, 204, 1.00);vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45622{width:1.548in;background-color:rgba(204, 204, 204, 1.00);vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45623{width:3.005in;background-color:rgba(204, 204, 204, 1.00);vertical-align: middle;border-bottom: 1.5pt solid rgba(102, 102, 102, 1.00);border-top: 1.5pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b4562a{width:2.722in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45634{width:0.956in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45635{width:1.875in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45636{width:1.883in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b4563e{width:1.548in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b4563f{width:3.005in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 0 solid rgba(0, 0, 0, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45648{width:2.722in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45652{width:0.956in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45653{width:1.875in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45654{width:1.883in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b4565c{width:1.548in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b4565d{width:3.005in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45666{width:2.722in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 0 solid rgba(0, 0, 0, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45670{width:0.956in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b45671{width:1.875in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b4567a{width:1.883in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b4567b{width:1.548in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 1pt solid rgba(102, 102, 102, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}.cl-22b4567c{width:3.005in;background-color:rgba(255, 255, 255, 1.00);vertical-align: middle;border-bottom: 1pt solid rgba(102, 102, 102, 1.00);border-top: 1pt solid rgba(102, 102, 102, 1.00);border-left: 1pt solid rgba(102, 102, 102, 1.00);border-right: 0 solid rgba(0, 0, 0, 1.00);margin-bottom:0;margin-top:0;margin-left:0;margin-right:0;}Intervention (N₁=66)Placebo (N₂=69)Treatment effect estimate (95% CI)Alanine Aminotransferase (IU/L)Week 0Mean (SD)56.6 (32)61.1 (34.9)NA (NA, NA)Median (IQR)55 (52.6)56.2 (58)Number of missing n10Week 4Mean (SD)61.6 (35.8)61.6 (35.1)Median (IQR)56.6 (69.5)61.8 (59.1)Number of missing n32Week 8Mean (SD)57.6 (32.5)64.4 (32.3)Median (IQR)53.3 (50.5)68.8 (58.1)Number of missing n31Week 12Mean (SD)60.8 (31.2)61.7 (34.3)Median (IQR)64.9 (47.4)59.3 (55.2)Number of missing n34Week 16Mean (SD)NA (NA)92.5 (NA)Median (IQR)NA (NA)92.5 (0)Number of missing n6668Week 20Mean (SD)61.3 (35)55.4 (30.8)Median (IQR)68.4 (63.3)60.6 (50.6)Number of missing n34Week 24Mean (SD)60.1 (31.3)61.2 (32.6)Median (IQR)60.9 (53.9)60.1 (52.9)Number of missing n45Lymphocytes (GI/L)Week 0Mean (SD)3.6 (1.9)3.2 (2)Median (IQR)3.5 (3.3)3 (3.2)Number of missing n12Week 4Mean (SD)3.6 (1.8)3.8 (2.1)Median (IQR)3.6 (2.5)3.7 (3.8)Number of missing n44Week 8Mean (SD)3.8 (2.1)4.2 (1.9)Median (IQR)3.5 (3.9)4.4 (3.6)Number of missing n32Week 12Mean (SD)3.8 (1.9)4.1 (1.9)Median (IQR)4 (2.9)4.3 (3.1)Number of missing n33Week 16Mean (SD)3.9 (2.1)4.1 (2)Median (IQR)3.8 (3.9)4.2 (3.4)Number of missing n25Week 20Mean (SD)3.9 (1.8)4 (2)Median (IQR)4 (2.5)4.1 (3.3)Number of missing n43Week 24Mean (SD)3.5 (1.9)3.9 (2.2)Median (IQR)3.4 (3.4)3.7 (3.9)Number of missing n44Neutrophils (GI/L)Week 0Mean (SD)12.6 (6.5)12 (7)Median (IQR)13.8 (11.5)11.4 (12.5)Number of missing n12Week 4Mean (SD)12.9 (6.4)11.3 (6.8)Median (IQR)12.9 (11.5)11 (12.3)Number of missing n44Week 8Mean (SD)11.8 (7.1)11.6 (6.8)Median (IQR)11.8 (13.2)10.4 (13)Number of missing n32Week 12Mean (SD)12.1 (6.8)12.2 (6.7)Median (IQR)11.1 (12.5)11.1 (12.5)Number of missing n33Week 16Mean (SD)12.7 (6.8)11.5 (7.2)Median (IQR)13 (11.8)12.2 (13.1)Number of missing n25Week 20Mean (SD)11.2 (6.7)12.1 (6.7)Median (IQR)10.3 (11.4)12.2 (10.3)Number of missing n43Week 24Mean (SD)12.4 (6.8)12.6 (6.2)Median (IQR)13.1 (12)13.3 (11.5)Number of missing n44"}]
